7 results on '"Siriwattanasathien Y"'
Search Results
2. Amaryllidaceae alkaloids from the bulbs of Crinum latifolium L. and their cholinesterase inhibitory activities.
- Author
-
Chaichompoo W, Rojsitthisak P, Pabuprapap W, Siriwattanasathien Y, Yotmanee P, and Suksamrarn A
- Subjects
- Butyrylcholinesterase, Acetylcholinesterase, Cholinesterase Inhibitors pharmacology, Cholinesterase Inhibitors chemistry, Plant Extracts pharmacology, Plant Extracts chemistry, Amaryllidaceae Alkaloids pharmacology, Amaryllidaceae Alkaloids chemistry, Crinum chemistry, Alkaloids pharmacology, Alkaloids chemistry
- Abstract
Eleven previously undescribed Amaryllidaceae alkaloids, crinalatifolines A-K (1-11), and two first naturally occurring alkaloids, dihydroambelline (12) and N-demethyldihydrogalanthamine (13), were isolated from the bulbs of Crinum latifolium L. Additionally, thirty-seven known alkaloids and one alkaloid artifact were also isolated from this plant species. Their structures and absolute configurations were elucidated using extensive spectroscopic techniques, including IR, NMR, MS, and ECD. Evaluations of the cholinesterase inhibitory activities of most of these compounds were conducted. Among the tested compounds, ungeremine exhibited the highest potency against acetylcholinesterase and butyrylcholinesterase, with the IC
50 values of 0.10 and 1.21 μM, respectively. These values were 9.4- and 2.4-fold more potent than the reference drug galanthamine., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
3. Alkaloids with cholinesterase inhibitory activities from the bulbs of Crinum × amabile Donn ex Ker Gawl.
- Author
-
Chaichompoo W, Rojsitthisak P, Pabuprapap W, Siriwattanasathien Y, Yotmanee P, and Suksamrarn A
- Subjects
- Butyrylcholinesterase, Acetylcholinesterase, Molecular Docking Simulation, Crinum
- Abstract
Seven previously undescribed alkaloids, crinamabilines A-G, two non-alkaloidal compounds, crinamabidiene and 6-phenylpiperonyl alcohol, two first naturally occurring alkaloids, 3-epibuphanisine and (+)-1β,2β-epoxy-epicrinine, together with nineteen known alkaloids, were isolated from the bulbs of Crinum × amabile Donn ex Ker Gawl. Their structures and absolute configurations were elucidated by NMR, MS and ECD spectroscopic techniques. Ungeremine displayed the most potent inhibitory activity against acetylcholinesterase (IC
50 0.21 μM), which was about 6-fold more active than the reference drug, galanthamine (IC50 1.23 μM). Ungeremine also exhibited the strongest inhibitory activity against butyrylcholinesterase (IC50 3.57 μM), which was comparable to galanthamine (IC50 3.11 μM). The molecular docking studies were performed and were well in agreement with the experimental results., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Elsevier Ltd. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
4. Morindaquinone, a new bianthraquinone from Morinda coreia roots.
- Author
-
Chokchaisiri S, Siriwattanasathien Y, Thongbamrer C, Suksamrarn A, and Rukachaisirikul T
- Subjects
- Anthraquinones chemistry, Anthraquinones isolation & purification, Breast Neoplasms metabolism, Humans, MCF-7 Cells drug effects, Anthraquinones pharmacology, Breast Neoplasms chemistry, Morinda, Plant Roots chemistry
- Abstract
Phytochemical investigation of the roots of Morinda coreia led to the isolation of one new bianthraquinone, morindaquinone ( 1 ), together with 12 known compounds, soranjidiol ( 2 ), rubiadin-1-methyl ether ( 3 ), 2-methoxy-1,3,6-trihydroxyanthraquinone ( 4 ), 1-hydroxy-2-methylanthraquinone ( 5 ), tectoquinone ( 6 ), nordamnacanthal ( 7 ), damnacanthal ( 8 ), 2-formylanthraquinone ( 9 ), 3-hydroxy-2-hydroxymethylanthraquinone ( 10 ), lucidin-ω-methyl ether ( 11 ), scopoletin ( 12 ) and (+)-mellein ( 13 ). The structures of these compounds were determined on the basis of extensive spectroscopic analyses, as well as by comparison with literature reports. Compound 1 was the first example of bianthraquinone found in the genus Morinda , whereas compound 13 was firstly isolated from this genus. Among them, compounds 2 , 7 , 8 and 10 exhibited moderate to weak cytotoxicity against human cervical (HeLa), human colon (HT 29) and human breast (MCF-7) cell lines, while compounds 6 and 9 - 11 showed weak anti-acetylcholinesterase activity.
- Published
- 2021
- Full Text
- View/download PDF
5. Stephapierrines A-H, new tetrahydroprotoberberine and aporphine alkaloids from the tubers of Stephania pierrei Diels and their anti-cholinesterase activities.
- Author
-
Chaichompoo W, Rojsitthisak P, Pabuprapap W, Siriwattanasathien Y, Yotmanee P, Haritakun W, and Suksamrarn A
- Abstract
Eight new alkaloids, which are four new tetrahydroprotoberberine alkaloids, stephapierrines A-D (1-4), and four new aporphine alkaloids, stephapierrines E-H (5-8), together with three new naturally occurring alkaloids (9-11) and thirty-four known alkaloids (12-45) were isolated from the tubers of Stephania pierrei Diels. The structures of the new compounds were elucidated by spectroscopic analysis and physical properties. The structures of the known compounds were characterized by comparison of their spectroscopic data with those previously reported. Compound 42 exhibited the strongest acetylcholinesterase (AChE) inhibitory activity, which was more active than galanthamine, the reference drug. Compound 23 showed the highest butyrylcholinesterase (BuChE) inhibitory activity, which was also more active than galanthamine. Molecular docking studies are in good agreement with the experimental results., Competing Interests: The authors declare no conflict of interest., (This journal is © The Royal Society of Chemistry.)
- Published
- 2021
- Full Text
- View/download PDF
6. Highly potent cholinesterase inhibition of geranylated xanthones from Garcinia fusca and molecular docking studies.
- Author
-
Saenkham A, Jaratrungtawee A, Siriwattanasathien Y, Boonsri P, Chainok K, Suksamrarn A, Namsa-Aid M, Pattanaprateeb P, and Suksamrarn S
- Subjects
- Acetylcholinesterase, Butyrylcholinesterase, Cholinesterase Inhibitors isolation & purification, Molecular Docking Simulation, Molecular Structure, Phytochemicals isolation & purification, Phytochemicals pharmacology, Structure-Activity Relationship, Thailand, Xanthones isolation & purification, Cholinesterase Inhibitors pharmacology, Garcinia chemistry, Plant Bark chemistry, Xanthones pharmacology
- Abstract
Three new oxygenated xanthones, fuscaxanthones L-N (1-3), and 14 known xanthones 4-17, together with the other known metabolites 18-20 were isolated from the stem barks of Garcinia fusca Pierre. Their chemical structures were determined based on NMR and MS spectroscopic data analysis, as well as single X-ray crystallography. The geranylated compounds, cowanin (13), cowagarcinone E (15), norcowanin (16) and cowanol (17) exhibited potent inhibitions against acetylcholinesterase (AChE) (IC
50 0.33-1.09 μM) and butyrylcholinesterase (BChE) (IC50 0.048-1.84 μM), which were more active than the reference drug, galanthamine. Compound 15 was highly potent BChE inhibitor (IC50 0.048 μM) and was 76-fold more potent than the drug. Structure-activity relationship studies indicated that the C-2 prenyl and C-8 geranyl substituents in the tetraoxygenated scaffold are important for high activity. Molecular docking studies revealed that the leads 13 and 15-17 showed similar binding orientations on both enzymes and very well-fitted at the double binding active sites of PAS and CAS with strong hydrophobic interactions from both isoprenyl side chains., Competing Interests: Conflict of interest The authors declare that there is no conflict of interest., (Copyright © 2020 Elsevier B.V. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
7. Phosphodiesterase 5 Inhibitors from Derris scandens.
- Author
-
Chaichamnong N, Temkitthawon P, Khorana N, Pitpakdeeanan P, Taepavarapruk P, Nuengchamnong N, Siriwattanasathien Y, Suksamrarn A, and Ingkaninan K
- Subjects
- Chromatography, Liquid, Coumarins chemistry, Coumarins isolation & purification, Coumarins pharmacology, Isoflavones chemistry, Isoflavones isolation & purification, Mass Spectrometry, Phosphodiesterase 5 Inhibitors chemistry, Phosphodiesterase 5 Inhibitors isolation & purification, Plant Extracts chemistry, Plant Extracts isolation & purification, Plant Stems chemistry, Derris chemistry, Isoflavones pharmacology, Phosphodiesterase 5 Inhibitors pharmacology, Plant Extracts pharmacology
- Abstract
Phosphodiesterase 5 inhibitors have been used as a first-line medicine for the treatment of erectile dysfunction. In the search for new phosphodiesterase 5 inhibitors from natural sources, we found that the 95% ethanol extract of Derris scandens stem showed phosphodiesterase 5 inhibitory activity with an IC
50 value of about 7 µg/mL. Seven isoflavones and a coumarin constituent isolated from this plant were investigated for phosphodiesterase 5 inhibitory activity. The results showed that osajin (8: ), 4',5,7-trihydroxybiprenylisoflavone (4: ), and derrisisoflavone A (2: ) had the ability to inhibit phosphodiesterase 5 with IC50 values of 4, 8, and 9 µM, respectively. These compounds exhibited selectivity on phosphodiesterase 5 over phosphodiesterase 1, however, the selectivity on phosphodiesterase 5 over phosphodiesterase 6 was low. In order to quantitatively determine these bioactive constituents in D. scandens extract, LC-QTOF-MS method has been developed and validated. The limit of quantitation values in the range of 0.1 - 5 µg/mL were obtained. The assay showed satisfactory precision and accuracy. The results from our method showed that the 95% ethanol extract of D. scandens stem was comprised of all eight compounds, with derrisisoflavone A (2: ) and lupalbigenin (3: ) presenting as the major constituents., Competing Interests: The authors declare no conflict of interest., (Georg Thieme Verlag KG Stuttgart · New York.)- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.